PRQRのニュース
How should investors view ProQR Therapeutics N.V. (PRQR)? 2023/01/03 13:48:00 US Post News
A share of ProQR Therapeutics N.V. (NASDAQ:PRQR) closed at $3.70 per share on Friday, up from $3.37 day before. While ProQR Therapeutics N.V. has overperformed by 9.79%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, PRQR fell by -54.71%, with highs and lows ranging from $8.60 […]
A stock that deserves closer examination: ProQR Therapeutics N.V. (PRQR) 2022/12/27 13:16:00 US Post News
ProQR Therapeutics N.V. (NASDAQ:PRQR) closed Friday at $2.71 per share, up from $2.70 a day earlier. While ProQR Therapeutics N.V. has overperformed by 0.37%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, PRQR fell by -66.95%, with highs and lows ranging from $8.60 to $0.53, whereas […]
ProQR Therapeutics N.V. (NASDAQ: PRQR) Stock Forecast: Bullish Signals Pointing To $5.00 In 2022 2022/12/27 12:30:00 Marketing Sentinel
In the last trading session, 5.55 million shares of the ProQR Therapeutics N.V. (NASDAQ:PRQR) were traded, and its beta was 0.48. Most recently the company’s share price was $2.71, and it changed around $0.01 or 0.37% from the last close, which brings the market valuation of the company to $192.90M. PRQR currently trades at a … ProQR Therapeutics N.V. (NASDAQ: PRQR) Stock Forecast: Bullish Signals Pointing To $5.00 In 2022 Read More »
ProQR Therapeutics N.V. PT Raised to $3 at Citi 2022/12/23 09:28:02 Investing.com
https://www.investing.com/news/pro/proqr-therapeutics-nv-pt-raised-to-3-at-citi-432SI-2969634
ICPT, ADPT and AMED are among after hour mover 2022/12/22 22:54:12 Seeking Alpha
Gainers: ORIC Pharmaceuticals (ORIC) +56%. ProQR Therapeutics (PRQR) +38%
Analysts Predict A Surge In ProQR Therapeutics N.V. (NASDAQ: PRQR)? 2022/06/25 11:00:00 Stocks Register
ProQR Therapeutics N.V. (NASDAQ:PRQR) shares, rose in value on Friday, 06/24/22, with the stock price down by -16.27% to the previous day’s close as strong demand from buyers drove the stock to $0.68. Actively observing the price movement in the last trading, the stock closed the session at $0.81, falling within a range of $0.68 … Analysts Predict A Surge In ProQR Therapeutics N.V. (NASDAQ: PRQR)? Read More »
ProQR to Present its Axiomer RNA Editing Technology at the Oligonucleotide and Peptide Therapeutics Conference (TIDES USA) 2022 2022/05/09 11:00:00 Wallstreet:Online
LEIDEN, Netherlands & CAMBRIDGE, Mass., May 09, 2022 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of transformative RNA therapies, today announced a presentation at the Oligonucleotide and Peptide Therapeutics conference, or TIDES USA, that is being held May 9-12, 2022 in Boston, MA, U.S. ProQR presentation
Expert Ratings for ProQR Therapeutics 2022/05/06 14:04:32 Benzinga
Within the last quarter, ProQR Therapeutics (NASDAQ: PRQR ) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 4 2 0 0 0 Last 30D 1 0 0 0 0 1M Ago 1 1 0 0 0 2M Ago 0 0 0 0 0 3M Ago 2 1 0 0 0 In the last 3 months, 6 analysts have offered 12-month price targets for ProQR Therapeutics. The company has an average price target of $4.92 with a high of $8.00 and a low of $2.00. Below is a summary of how these 6 analysts rated ProQR Therapeutics over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the … Full story available on Benzinga.com
ProQR Announces First Quarter 2022 Operating and Financial Results 2022/05/05 20:30:00 GlobeNewswire
LEIDEN, Netherlands & CAMBRIDGE, Mass., May 05, 2022 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of transformative RNA therapies, today reported its financial and operating results for the first quarter ended March 31, 2022, and provided a business update.
ProQR Therapeutics (PRQR) Investor Presentation - Slideshow 2022/04/29 17:50:54 Seeking Alpha
The following slide deck was published by ProQR Therapeutics N.V.
ProQR Therapeutics (PRQR) Investor Presentation - Slideshow 2022/04/29 17:50:54 Seeking Alpha
The following slide deck was published by ProQR Therapeutics N.V.
Enrapturing stocks: Powerbridge Technologies Co., Ltd. (NASDAQ:PBTS 7.84%), ProQR Therapeutics N.V. (NASDAQ:PRQR -0.39%) 2022/04/15 18:54:16 Stock Equity
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Enrapturing stocks: Powerbridge Technologies Co., Ltd. (NASDAQ:PBTS 7.84%), ProQR Therapeutics N.V. (NASDAQ:PRQR -0.39%) appeared first on Stocks Equity .
ProQR Therapeutics Pulls Plug On Inherited Retinal Disease Programs, Cuts 30% Workforce 2022/04/13 13:49:29 Benzinga
ProQR Therapeutics N.V. (NASDAQ: PRQR ) has decided to prioritize the development of genetic eye disease candidates and the Axiomer RNA base-editing technology platform. The Company will suspend the development of QR-1123 for autosomal dominant retinitis pigmentosa, QR-504a for Fuchs endothelial corneal dystrophy, and all other Inherited Retinal diseases (IRD)-related research activities. ProQR will implement restructuring initiatives, including a 30% workforce reduction and the departure of Chief Scientific Officer Naveed Shams, expected to be effective in Q2. ProQR … Full story available on Benzinga.com
Glistering Stock: ProQR Therapeutics N.V. (NASDAQ:PRQR), Enservco Corporation (AMEX:ENSV) 2022/03/08 04:20:09 Stock Equity
ProQR Therapeutics N.V. (NASDAQ:PRQR) with the stream of 3.15% also noticed, India Enservco Corporation (AMEX:ENSV) encountered a rapid change of 85.19% in the last hour of Monday’s trading session. ProQR … The post Glistering Stock: ProQR Therapeutics N.V. (NASDAQ:PRQR), Enservco Corporation (AMEX:ENSV) appeared first on Stocks Equity .
Is ProQR Therapeutics N.V. (NASDAQ: PRQR) Still A Loss Stock Despite Being Down -85.02% YTD? 2022/02/18 16:30:00 Marketing Sentinel
During the last session, ProQR Therapeutics N.V. (NASDAQ:PRQR)’s traded shares were 3.38 million, with the beta value of the company hitting 0.57. At the end of the trading day, the stock’s price was $1.20, reflecting an intraday loss of -1.64% or -$0.02. The 52-week high for the PRQR share is $9.46, that puts it down … Is ProQR Therapeutics N.V. (NASDAQ: PRQR) Still A Loss Stock Despite Being Down -85.02% YTD? Read More »